Cytodel Inc is a biotech company based in New York City, specializing in the development of recombinant BoNT (botulinum neurotoxin) for intra-neuronal delivery. With laboratory and office facilities located at Harlem Biospace, they are at the forefront of biotech innovation.
Driven by a dedicated management team and board of directors, Cytodel Inc focuses on biodefense and discovery programs, aiming to provide effective solutions for various medical applications through their cutting-edge technology and bioengineering expertise.
Generated from the website